By expenditures
| Name | Title | Type |
|---|---|---|
| Travis Heneveld | Interim CEO | Auditee |
| Walt Derengowski | Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 343616 | 2023 | 2025-02-24 | Gelman Rosenberg & Freedman | $1.36M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 343616 | 2023 | 2025-02-24 | 1100825 | 2023-003 | Material Weakness | - | I |
| 343616 | 2023 | 2025-02-24 | 1100824 | 2023-002 | Significant Deficiency | - | P |
| 343616 | 2023 | 2025-02-24 | 1100823 | 2023-003 | Material Weakness | - | I |
| 343616 | 2023 | 2025-02-24 | 1100822 | 2023-002 | Significant Deficiency | - | P |
| 343616 | 2023 | 2025-02-24 | 1100821 | 2023-003 | Material Weakness | - | I |
| 343616 | 2023 | 2025-02-24 | 1100820 | 2023-002 | Significant Deficiency | - | P |
| 343616 | 2023 | 2025-02-24 | 524383 | 2023-003 | Material Weakness | - | I |
| 343616 | 2023 | 2025-02-24 | 524382 | 2023-002 | Significant Deficiency | - | P |
| 343616 | 2023 | 2025-02-24 | 524381 | 2023-003 | Material Weakness | - | I |
| 343616 | 2023 | 2025-02-24 | 524380 | 2023-002 | Significant Deficiency | - | P |
| 343616 | 2023 | 2025-02-24 | 524379 | 2023-003 | Material Weakness | - | I |
| 343616 | 2023 | 2025-02-24 | 524378 | 2023-002 | Significant Deficiency | - | P |